Skip to main content
Clinical Trials/NCT01396616
NCT01396616
Unknown
Phase 4

Clinical Evaluation of Toric Intraocular Lens Made by Aurolab

Aurolab1 site in 1 country120 target enrollmentAugust 2011
ConditionsAstigmatism

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Astigmatism
Sponsor
Aurolab
Enrollment
120
Locations
1
Primary Endpoint
vision improvement
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to measure visual acuity and Intraocular Lens (IOL) rotational stability after implantation of TORIC IOL and to assess the post operative complications after implantation of TORIC IOL.

Detailed Description

Among available methods for treating astigmatism in cataract surgery, the implantation of toric IOLs is an emerging technology that shows promising results. Similar to implanting a one-piece acrylic lens, toric IOLs provide good distance vision and, in many patients, freedom from spectacles for distance vision. A low absolute residual refractive cylinder has been associated with the implantation of toric IOLs, and the safety profile for toric IOLs has been good. As improvements with regard to rotational stability and treatment and cylinder power range are made, toric IOLs will emerge as an effective, safe treatment option for correcting astigmatism during cataract surgery. Further, to evidence on the safety and efficacy of TORIC IOL for patients having cataract associated with astigmatism served as the basis for us to identify the published literature on the safety and efficacy of TORIC IOL implantation in the treatment of cataract associated with astigmatism, thus provide a background for the development of clinical investigation plan for the present study.

Registry
clinicaltrials.gov
Start Date
August 2011
End Date
June 2013
Last Updated
13 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Aurolab
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 40 to 65
  • Senile cataract
  • Posterior Sub Capsular Cataract (PSCC)
  • Astigmatism 1.25 D or more
  • Residence within 100 kms of Madurai

Exclusion Criteria

  • Traumatic \& Complicated cataract
  • Poor mydriasis
  • Amblyopia
  • Severe Pseudo exfoliation (PXF)
  • Dense posterior polar cataract (PPC)
  • One eyed patients
  • Corneal pathology / Scar
  • Retinal Pathology contributing to visual loss
  • Intraoperative complication like PC rupture, Zonular dialysis

Outcomes

Primary Outcomes

vision improvement

Time Frame: 150 days

The visual acuity will be measured after iol implantation on 1 day, 10 days, 40 days and 150 days post operatively

Secondary Outcomes

  • Refractive error correction(150 days)

Study Sites (1)

Loading locations...

Similar Trials